Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella

BOSTON, June 2, 2016 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced that Frank C. Condella, Jr., plans to retire as ... Biopharmaceuticals, Drug Delivery, PersonnelJuniper Pharmaceuticals, intravaginal drug delivery
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news